TGF-β can also induce tumor cells to overexpress IL-10 to activate Th2 while inhibiting Th1 immune activity, thereby breaking the balance of Th1 / Th2, and ultimately suppressing immune killing of tumor cells 35. The gene discussed is TGFB1; the disease is neoplasm.